Preparation and evaluation of recombinant human bone morphogenetic protein-2 loaded microsphere

Pei-fu Tang,Qi Yao,Hua-yan Sun,Peng Huang,Geng Cui,Ji-fang Wang
DOI: https://doi.org/10.3321/j.issn:1673-8225.2008.06.002
2008-01-01
Abstract:AIM: Recombinant human bone morphogenetic protein-2 (rhBMP-2) is prone to dilute and conduct metabolism, with a short half-life period in vivo. This study investigated the feasibility and the preparation of rhBMP-2 carrying poly (lactic-co-glycolide) (PLGA), and observed drug-loading and drug-releasing function. METHODS: ①The rhBMP-2/PLGA microspheres were prepared using W/O/W solvent evaporation method. The particle size and morphology of the microspheres, the drug loading, the efficiency of encapsulation and in vitro release behaviors were detected.② PLGA microspheres containing 50 mg rhBMP-2 were implanted into medial vastus muscle pouches of right lateral thigh in 12 Kunming mice, and the ectopic bone formation and the activity of rhBMP-2 released from the microspheres were evaluated 4 weeks later by the heterotopia bone formation experiment. RESULTS: ①The rhBMP-2/PLGA microspheres showed good morphology with the particles diameter at 50-60 μm, the envelopment ratio (37.52±4.31)%, and the ratio of drug loading (5.12±1.32)%.②Initial burst release of the microspheres occurred, the drug release exceeded 40% within 7 days, and approximately 90% of the drugs was released within 42 days.③Four weeks after the rhBMP-2/PLGA implanted into muscle pouches of mice, obvious bone formation was detectable histologically. CONCLUSION: The rhBMP-2/PLGA microspheres can release slowly active rhBMP-2, showing a potential clinical application.
What problem does this paper attempt to address?